Most Active Biotech Investors in San Mateo 2026

5 firms writing Biotech checks in San Mateo, led by HBM Healthcare Investments, MiddleGround Capital.

Biotech in San Mateo accounts for 6 tracked companies with verified cap-table data, 6 of which disclose round sizes totalling $998M. The median disclosed raise is $223M, and the largest is EndoGastric Solutions at $374M, ahead of Bluejay Therapeutics ($243M) and AusperBio ($223M).

The names that recur most often on these biotech cap tables are GV (2 companies), Accelmed (1 company), Advanced Technology Ventures (1 company), Canaan Partners (1 company), CRG (1 company), T. Rowe Price (1 company). By latest disclosed round, the market skews Series A (3), Series I (1), Series C (1), Series B (1).

Companies tracked: 6
Disclosed funding total: $998M across 6 companies
Median disclosed raise: $223M
Largest raise: EndoGastric Solutions — $374M
Stage mix: Series A 3 · Series I 1 · Series C 1 · Series B 1
Most recent dated round: 2025-05-28

Best funded Biotech in San Mateo companies

EndoGastric Solutions — $374M (latest: Series I)
Bluejay Therapeutics — $243M (latest: Series C)
AusperBio — $223M (latest: Series B)
Helicore Biopharma — $65M (latest: Series A)
EpiBiologics — $50M (latest: Series A)
Arda Therapeutics — $43M (latest: Series A)

Sector × city funding reports (20)

All research · Investor directory · Company funding database · Fundraising library